The Valley Desk

Clinical trial reportGastroenterologyPublished

Efficacy and Safety of Guselkumab Subcutaneous Induction and Maintenance in Participants With Moderately to Severely Active Crohn's Disease: Results From the Phase 3 GRAVITI Study

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
Gastroenterology
Published
Subject terms
Humans; Crohn Disease; Gastrointestinal Agents; Treatment Outcome; Remission Induction; Injections, Subcutaneous; Severity of Illness Index; Double-Blind Method; Adolescent; Adult; Middle Aged; Female
PubMed ID
40113101
Added to directory
Source checked

Report a correction or request removal